Tina Wood, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Photodynamic Therapy Targeted Therapy
Dr. Tina Wood graduated the medical school from Wake Forest School of Medicine and completed both her residency and fellowship program at University of Alabama Medical Center. She is specialized and also board certified in Medical Oncology. Dr. Wood has been in practice for more than 11 years and is affiliated with USA Children's & Women's Hospital. During her career, she has also contributed to four publications of medical interest.
Wake Forest School of Medicine
Medical School
University of Alabama Medical Center
Residency
University of Alabama Medical Center
Fellowship
American Board of Internal Medicine - Oncology
Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone.
McDonald, A. M.,Dulaney, C. R.,López-Araujo, J.,Posey, J. A.,Keene, K. S.,Christein, J. D.,Heslin, M. J.,Wood, T. E.,Jacob, R.; J Gastrointest Cancer. 2015 Mar 19.
See more >>By the pricking of my thumbs, something wicked this way comes: sporadic cancers versus eponymous hereditary cancer predisposition syndromes.
Vaklavas, C., Ross, J.R., Nabell, L.M., Forero, A., Heslin, M.J., Wood, T.E.; J Natl Compr Canc Netw. 2012 Jan.
See more >>Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial.
Von Hoff, D.D., Ramanathan, R.K., Borad, M.J., Laheru, D.A., Smith, L.S., Wood, T.E., Korn, R.L., Desai, N., Trieu, V., Iglesias, J.L., Zhang, H., Soon-Shiong, P., Shi...; J Clin Oncol. 2011 Dec 1.
See more >>